{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:20:53Z","timestamp":1790871653886,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001027","name":"Department of Health and Ageing, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.brainres.2010.08.070","type":"journal-article","created":{"date-parts":[[2010,9,2]],"date-time":"2010-09-02T04:39:32Z","timestamp":1283402372000},"page":"119-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Progressive loss of dopaminergic neurons induced by unilateral rotenone infusion into the medial forebrain bundle"],"prefix":"10.1016","volume":"1360","author":[{"given":"Anwar","family":"Norazit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian C.B.","family":"Meedeniya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Nga","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Mackay-Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2010.08.070_bb0005","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1046\/j.1471-4159.2003.02068.x","article-title":"The pesticide rotenone induces caspase-3-mediated apoptosis in ventral mesencephalic dopaminergic neurons","volume":"87","author":"Ahmadi","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2010.08.070_bb0010","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0166-4328(02)00180-8","article-title":"Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats","volume":"136","author":"Alam","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2010.08.070_bb0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbr.2003.08.014","article-title":"The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by l-DOPA","volume":"151","author":"Alam","year":"2004","journal-title":"Behav. Brain Res."},{"issue":"Suppl","key":"10.1016\/j.brainres.2010.08.070_bb0020","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/nrn1434","article-title":"Oxidative stress in neurodegeneration: cause or consequence?","volume":"10","author":"Andersen","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.brainres.2010.08.070_bb0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1017\/S1461145703004036","article-title":"Protective effect of 1-methyl-1, 2, 3, 4-tetrahydroisoquinoline against dopaminergic neurodegeneration in the extrapyramidal structures produced by intracerebral injection of rotenone","volume":"7","author":"Antkiewicz-Michaluk","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2010.08.070_bb0030","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainres.2010.08.070_bb0035","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/bies.10067","article-title":"Animal models of Parkinson's disease","volume":"24","author":"Betarbet","year":"2002","journal-title":"Bioessays"},{"key":"10.1016\/j.brainres.2010.08.070_bb0040","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1602\/neurorx.2.3.484","article-title":"Toxin-induced models of Parkinson's disease","volume":"2","author":"Bove","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.brainres.2010.08.070_bb0045","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1242\/jcs.01356","article-title":"Regulation of cytoplasmic stress granules by apoptosis-inducing factor","volume":"117","author":"Cande","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.brainres.2010.08.070_bb0050","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A highly reproducible rotenone model of Parkinson's disease","volume":"34","author":"Cannon","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2010.08.070_bb0055","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"issue":"Suppl","key":"10.1016\/j.brainres.2010.08.070_bb0060","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nn941","article-title":"Neuroprotective and neurorestorative strategies for Parkinson's disease","volume":"5","author":"Dawson","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainres.2010.08.070_bb0065","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0005-2728(98)00029-2","article-title":"Inhibitors of NADH\u2013ubiquinone reductase: an overview","volume":"1364","author":"Degli Esposti","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.brainres.2010.08.070_bb0070","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/ana.20143","article-title":"Further evidence that interactions between CYP2D6 and pesticide exposure increase risk for Parkinson's disease","volume":"55","author":"Deng","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2010.08.070_bb0075","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/exnr.2002.7891","article-title":"Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway","volume":"175","author":"Deumens","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2010.08.070_bb0080","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.cdd.4400430","article-title":"Apoptosis: who was first?","volume":"5","author":"Esposti","year":"1998","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.brainres.2010.08.070_bb0085","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1749-6632.2003.tb07469.x","article-title":"Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease","volume":"991","author":"Fiskum","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.brainres.2010.08.070_bb0090","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1046\/j.1471-4159.1998.70010268.x","article-title":"Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay","volume":"70","author":"Floor","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2010.08.070_bb0095","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1073\/pnas.86.7.2493","article-title":"Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsy","volume":"86","author":"Girault","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2010.08.070_bb0100","doi-asserted-by":"crossref","first-page":"11465","DOI":"10.1074\/jbc.M111428200","article-title":"alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells","volume":"277","author":"Hashimoto","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2010.08.070_bb0105","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1017\/S0317167100052835","article-title":"A case\u2013control study of Parkinson's disease in urban population of southern Israel","volume":"28","author":"Herishanu","year":"2001","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.brainres.2010.08.070_bb0110","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1212\/WNL.39.10.1314","article-title":"Epidemiologic study of Parkinson's disease in Hong Kong","volume":"39","author":"Ho","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2010.08.070_bb0115","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","article-title":"Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains","volume":"106","author":"Imamura","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2010.08.070_bb0120","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/01.jnen.0000195941.48033.eb","article-title":"Upregulation of protease-activated receptor-1 in astrocytes in Parkinson disease: astrocyte-mediated neuroprotection through increased levels of glutathione peroxidase","volume":"65","author":"Ishida","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"Suppl 3","key":"10.1016\/j.brainres.2010.08.070_bb0125","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson's disease","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2010.08.070_bb0130","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1042\/bst0300963","article-title":"Stress granules: sites of mRNA triage that regulate mRNA stability and translatability","volume":"30","author":"Kedersha","year":"2002","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.brainres.2010.08.070_bb0135","doi-asserted-by":"crossref","first-page":"39414","DOI":"10.1074\/jbc.M406576200","article-title":"Inhibitors of the quinone-binding site allow rapid superoxide production from mitochondrial NADH:ubiquinone oxidoreductase (complex I)","volume":"279","author":"Lambert","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2010.08.070_bb0140","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0753-3322(99)80077-8","article-title":"Pesticides and Parkinson's disease","volume":"53","author":"Le Couteur","year":"1999","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.brainres.2010.08.070_bb0145","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1016\/S0028-3908(00)00110-6","article-title":"Alpha and beta nicotinic acetylcholine receptors subunits and synaptophysin in putamen from Parkinson's disease","volume":"39","author":"Martin-Ruiz","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2010.08.070_bb0150","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0140-6736(98)03453-9","article-title":"Parkinson's disease, pesticides, and glutathione transferase polymorphisms","volume":"352","author":"Menegon","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2010.08.070_bb0155","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1471-4159.2005.03112.x","article-title":"Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: protective effect of coenzyme Q10","volume":"93","author":"Moon","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2010.08.070_bb0160","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1634\/stemcells.2008-0074","article-title":"Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease","volume":"26","author":"Murrell","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.brainres.2010.08.070_bb0165","unstructured":"Nguyen, M.N., Cavanagh, B., Davenport, T., Norazit, A., Meedeniya, A., 2010. Tissue processing for epifluoresence microscopy, In: M\u00e9ndez-Vilas, A., Diaz, J. (Eds.), Microscopy: Science, Technology, Applications and Education, Vol. 4, Formatex, Badajoz, Spain."},{"key":"10.1016\/j.brainres.2010.08.070_bb0170","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.brainres.2010.08.070_bb0175","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1006\/meth.1999.0818","article-title":"Quantitative histology using confocal microscopy: implementation of unbiased stereology procedures","volume":"18","author":"Peterson","year":"1999","journal-title":"Methods"},{"key":"10.1016\/j.brainres.2010.08.070_bb0180","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.expneurol.2005.10.018","article-title":"alpha-Synuclein is upregulated in neurones in response to chronic oxidative stress and is associated with neuroprotection","volume":"199","author":"Quilty","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2010.08.070_bb0185","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.neuint.2006.02.003","article-title":"Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration","volume":"49","author":"Radad","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainres.2010.08.070_bb0190","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.vascn.2007.10.003","article-title":"The exploration of rotenone as a toxin for inducing Parkinson's disease in rats, for application in BBB transport and PK-PD experiments","volume":"57","author":"Ravenstijn","year":"2008","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.brainres.2010.08.070_bb0195","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/00207450490249338","article-title":"Astroglial and microglial activation in the wistar rat ventral tegmental area after a single striatal injection of 6-hydroxydopamine","volume":"114","author":"Rodrigues","year":"2004","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.brainres.2010.08.070_bb0200","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.brainres.2005.04.051","article-title":"Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease","volume":"1049","author":"Saravanan","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2010.08.070_bb0205","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/A:1006852306789","article-title":"The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases","volume":"174","author":"Schulz","year":"1997","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.brainres.2010.08.070_bb0210","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1634\/stemcells.2004-0114","article-title":"Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture","volume":"22","author":"Schulz","year":"2004","journal-title":"Stem Cells"},{"key":"10.1016\/j.brainres.2010.08.070_bb0215","doi-asserted-by":"crossref","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","article-title":"Mechanism of toxicity in rotenone models of Parkinson's disease","volume":"23","author":"Sherer","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2010.08.070_bb0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/exnr.2002.8072","article-title":"Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation","volume":"179","author":"Sherer","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2010.08.070_bb0225","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainres.2005.05.051","article-title":"Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion","volume":"1051","author":"Sindhu","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2010.08.070_bb0230","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.pbb.2006.05.017","article-title":"Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine","volume":"84","author":"Sindhu","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2010.08.070_bb0235","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0166-2236(89)90135-5","article-title":"The role of environmental toxins in the etiology of Parkinson's disease","volume":"12","author":"Tanner","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.brainres.2010.08.070_bb0240","doi-asserted-by":"crossref","first-page":"9207","DOI":"10.1523\/JNEUROSCI.20-24-09207.2000","article-title":"The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease","volume":"20","author":"Thiruchelvam","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2010.08.070_bb0245","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1006\/exnr.1994.1054","article-title":"A 6-hydroxydopamine-induced selective parkinsonian rat model: further biochemical and behavioral characterization","volume":"126","author":"Thomas","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2010.08.070_bb0250","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1113\/jphysiol.2003.049478","article-title":"Mitochondrial formation of reactive oxygen species","volume":"552","author":"Turrens","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.brainres.2010.08.070_bb0255","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00019052-200108000-00009","article-title":"The role of glial cells in Parkinson's disease","volume":"14","author":"Vila","year":"2001","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.brainres.2010.08.070_bb0260","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1515\/REVNEURO.2009.20.2.85","article-title":"Slowly progressive dopamine cell loss\u2014a model on which to test neuroprotective strategies for Parkinson's disease?","volume":"20","author":"Wright","year":"2009","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.brainres.2010.08.070_bb0265","doi-asserted-by":"crossref","first-page":"e7878","DOI":"10.1371\/journal.pone.0007878","article-title":"Stereotaxical infusion of rotenone: a reliable rodent model for Parkinson's disease","volume":"4","author":"Xiong","year":"2009","journal-title":"PLoS One"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899310018846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899310018846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:05:14Z","timestamp":1781107514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899310018846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":53,"alternative-id":["S0006899310018846"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2010.08.070","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progressive loss of dopaminergic neurons induced by unilateral rotenone infusion into the medial forebrain bundle","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2010.08.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}